|
|
|
Volumn 6, Issue 1, 2000, Pages 317-318
|
|
Therapy of B-cell lymphoma with anti-CD20 antibodies can result in loss of CD20 antigen expression [2] (multiple letters)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD20 ANTIGEN;
MONOCLONAL ANTIBODY;
RITUXIMAB;
ANTINEOPLASTIC AGENT;
ANTIGEN EXPRESSION;
B CELL LYMPHOMA;
B LYMPHOCYTE;
CANCER IMMUNOTHERAPY;
DRUG MECHANISM;
LETTER;
LYMPHOCYTE DEPLETION;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
GENE EXPRESSION REGULATION;
GENETICS;
HUMAN;
IMMUNOLOGY;
NOTE;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD20;
ANTINEOPLASTIC AGENTS;
B-LYMPHOCYTES;
GENE EXPRESSION REGULATION;
HUMANS;
LYMPHOCYTE DEPLETION;
LYMPHOMA, B-CELL;
|
|
EID: 0033969977
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (10)
|
|
References (0)
|